Check out what we’ve been up to and where can we connect!
November 20, 2020
The U.S. FDA granted emergency use authorization (EUA) for the use of baricitinib in combination with remdesivir to treat COVID-19 in hospitalized adults and children at least two years of age requiring supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.
October 20, 2020
Rob King of FHI Clinical recently spoke with the editor for Outsourcing-Pharma about the Oracle Health Sciences and FHI Clinical collaboration to improve clinical trial efficiency and help get therapies to market faster.
October 16, 2020
Development and ongoing activities of the China Tuberculosis Clinical Trials Consortium (CTCTC) were described in an article published in the Infectious Diseases of Poverty journal earlier this year. Read more, including FHI Clinical’s role in providing the network with technical support and guidance for clinical trial capacity building.
October 12, 2020
Oracle Health Sciences and FHI Clinical Inc. have joined efforts to improve clinical trial efficiency and help get therapies to market faster. FHI Clinical has adopted Oracle Health Sciences Clinical One for randomization, supply management, and data collection; Oracle Argus Safety for safety case management; Oracle CTMS Cloud Service to manage the entire research portfolio; and Oracle ClearTrial Cloud Service to help budget, plan and bid on projects.
September 27, 2021
In this webcast we will explore the intended purpose of ICH regulations; what organizations stand to gain from adopting the updated guidelines; how organizations can improve their operational efficiencies by minimizing duplicate quality-assurance steps; strategies for quick, relatively straightforward adoption of the new guidelines.
June 2, 2021
FHI Clinical is proud to support Making it Plain: the Colors of COVID Barbershop and Salon Talk including our Scientific Advisory Expert, Dr. Stephen Thomas, PhD.
April 29, 2021
Biomedical researchers, clinical research organizations, people infected and impacted by the pandemic, along with Black barbers and stylists, will come together in a virtual event April 29 at 6 p.m. to provide straight talk about fears, trust issues, and why we need our Black and Brown community to be part of COVID-19 vaccine research.
April 20-22, 2021
Attending the Global Forum on TB Vaccines? Visit our booth to learn more about our services or schedule a meeting with our team.
April 21, 2021
Join us for this panel discussion in which experts in infectious diseases will discuss the effect of WHO recommendations around TPT for individuals at high risk of TB infection and increased TPT use on TB vaccine development.
March 26, 2021
Bring all your questions about things like vaccine hesitancy, equitable vaccine distribution and other issues facing the black community to “Colors of COVID-19 Barber Shop and Salon Talk.”
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA